Recent studies have highlighted a subset of CD8+ T-cells that express CD14 and may play an immunomodulatory role, particularly in response to chronic inflammation or persistent antigen exposure, such as during hepatic viral responses and tumor infiltration in cancer [21]. This evidence concerns the gene CD8A and neoplasm.